SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Mar 29, 2017
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: March 29, 2017 · CIK: 0001095981 · Accession: 0000000000-17-010446
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216947
Letter
March 29, 2017 Marc H. Hedrick, M.D. President and Chief Executive Officer Cytori Therapeutics, Inc . 3020 Callan Road San Diego, CA 92121
Re: Cytori Therapeutics, Inc . Registration Statement on Form S-3 Filed March 27, 2017 File No. 333-216947
Dear Dr. Hedrick :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Brian Soares at (202) 551 -3580 with any questions.
Sincerely,
/s/ Brian Soares for
Show Raw Text
March 29, 2017 Marc H. Hedrick, M.D. President and Chief Executive Officer Cytori Therapeutics, Inc . 3020 Callan Road San Diego, CA 92121 Re: Cytori Therapeutics, Inc . Registration Statement on Form S-3 Filed March 27, 2017 File No. 333-216947 Dear Dr. Hedrick : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Brian Soares at (202) 551 -3580 with any questions. Sincerely, /s/ Brian Soares for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Chester J. Larson , Esq. Latham & Watkins LLP